SpectraCure AB (OSTO:SPEC) Total Operating Expense: kr67.62 Mil (TTM As of Mar. 2026)


What is SpectraCure AB Total Operating Expense?

SpectraCure AB OSTO:SPEC +3.45% Total Operating Expense is kr67.62 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

SpectraCure AB's Total Operating Expense for the three months ended in Mar. 2026 was kr8.94 Mil. SpectraCure AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr67.62 Mil.

SpectraCure AB Total Operating Expense Related Terms

SpectraCure AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB Total Operating Expense Chart

SpectraCure AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.59 30.00 32.38 33.57 66.20

SpectraCure AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.79 8.94 37.67 12.07 8.94

SpectraCure AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr67.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr67.62 Mil mean?
SpectraCure AB (OSTO:SPEC) has a Total Operating Expense of kr67.62 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on SpectraCure AB and its competitors.
Is SpectraCure AB's Total Operating Expense too high?
SpectraCure AB's current Total Operating Expense is kr67.62 Mil.
How does SpectraCure AB's Total Operating Expense compare to ABT and SYK?
SpectraCure AB's Total Operating Expense of kr67.62 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current Total Operating Expense is kr67.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Total Operating Expense of kr67.62 Mil. The current Total Operating Expense is kr67.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Total Operating Expense is kr67.62 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.